07.11.15, 9:14| Regulatory information
Trade subject to notification - Medi-Stim
After this transaction Orkla owns 1 500 000 shares in Medi-Stim which is 7.95 % of the share capital.
Ref.:
Rune Helland, SVP Investor Relations, Tel: +47 2254 4411